Creo Medical Group PLC (CREO) — Cash Flow-to-Debt Ratio
Creo Medical Group PLC (CREO) has a Cash Flow-to-Debt Ratio of -3.76x as of December 2025, meaning its operating cash flow of GBX-34.20 Million could theoretically repay -4% of its total liabilities (GBX9.10 Million) in one year. See financial agility of Creo Medical Group PLC to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Creo Medical Group PLC Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Creo Medical Group PLC across 14 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Creo Medical Group PLC.
Annual Cash Flow-to-Debt Ratio for Creo Medical Group PLC (2014–2025)
Year-by-year debt coverage analysis for Creo Medical Group PLC. Check CREO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.04x | GBX-18.60 Million | GBX9.10 Million | ▼ -108.1% |
| 2024 | -0.98x | GBX-22.20 Million | GBX22.60 Million | ▲ +23.6% |
| 2023 | -1.29x | GBX-21.60 Million | GBX16.80 Million | ▼ -33.4% |
| 2022 | -0.96x | GBX-24.99 Million | GBX25.93 Million | ▼ -1.2% |
| 2021 | -0.95x | GBX-25.98 Million | GBX27.29 Million | ▼ -75.5% |
| 2020 | -0.54x | GBX-16.09 Million | GBX29.66 Million | ▲ +73.7% |
| 2019 | -2.06x | GBX-11.54 Million | GBX5.60 Million | ▲ +70.5% |
| 2018 | -6.98x | GBX-14.20 Million | GBX2.03 Million | ▼ -128.6% |
| 2018 | -3.05x | GBX-7.00 Million | GBX2.29 Million | ▲ +35.0% |
| 2017 | -4.70x | GBX-6.91 Million | GBX1.47 Million | ▼ -126.0% |
| 2016 | -2.08x | GBX-1.64 Million | GBX788.81K | ▲ +64.6% |
| 2016 | -5.87x | GBX-3.13 Million | GBX532.79K | ▲ +23.7% |
| 2015 | -7.69x | GBX-2.27 Million | GBX295.98K | ▼ -41.3% |
| 2014 | -5.44x | GBX-1.36 Million | GBX250.20K | — |